UCL academic delegation’s visit to the healthcare enterprises in Germany

Earlier this month, TRO’s Senior Business and Innovation Manager Dr David Collier led a UCL academic delegation visit to healthcare enterprises near Dusseldorf, Germany to:
 

• exchange knowledge and ideas on life sciences and biomedical research
• build on existing relationships and Germany-UK collaborations in science and innovation
• forge new partnerships with industry in Germany

We cannot wait to continue building on these strategic links and support the growth of industry-academia partnerships along the translational pathway!
 
In the photo:
We thank QIAGEN for receiving the UCL delegation. 
Back row left to right - Thorsten Singer (QIAGEN); Daniel Wetterskog (UCL); Abhishek Sharma (QIAGEN); Martin Schlumpberger (QIAGEN); Siggi Hauch (QIAGEN)
Front row left to right - Stefan Guldin (UCL); Gert Attard (UCL); David Collier (UCL); Pascale Guillot (UCL); Constanze Kindler (QIAGEN)

Interested to stay informed of upcoming news, events and funding calls?

• Subscribe to our newsletter and you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations
• Follow us on social media (LinkedIn, Twitter) and stay tuned to our news and updates.

  ---

   

• TRO has created an online, internal portal (UCL sign-in required) to showcase the breadth of biomedical expertise at UCL and our partner hospitals, aiming to facilitate multidisciplinary collaborations and capabilities mapping. 

• Input your profile to get your capabilities visible across UCL experts and potentially external partners facilitated by TRO, leading to collaboration and funding opportunities.